Routine Urine Cytology Has no Role in Hematuria Investigations

Said F. Mishriki, Omar Aboumarzouk, Ross Vint, Samuel J S Grimsley, Thomas Lam, Bhaskar Somani

Research output: Contribution to journalArticle

11 Citations (Scopus)
4 Downloads (Pure)

Abstract

PURPOSE: Urine Cytology has been a longstanding first line investigation for haematuria and is recommended in current major guidelines. Objectives are to determine the contribution of urine cytology in haematuria investigations and its cost implications MATERIALS AND METHODS: Data prospectively collected for 2778 consecutive patients investigated for haematuria at a UK teaching hospital January 1999 to September 2007 with final analysis in October 2010. All patients underwent standard haematuria investigations; urine cytology, flexible cystoscopy and renal tract US with IVU or CTU performed for visible haematuria patients without diagnosis following first line tests. Patients with positive urine cytology as the only finding underwent further cystoscopy, retrograde studies or ureteroscopy with biopsy under general anaesthetic. Outcome in terms of eventual diagnosis were cross-referenced with initial urine cytology results (classified as malignant, suspicious, atypical, benign or unsatisfactory). Cost of urine cytology was calculated. RESULTS: 124 (4·5%) patients had malignant cells and 260 (9·4%) atypical/ suspicious. For urothelial cancer cytology demonstrated 45·5% sensitivity and 89·5% specificity. Two patients with urine cytology as the only positive finding had urothelial malignancy on further investigation. For the entire cohort, cost for cytology was £111,120. CONCLUSIONS: Routine urine cytology is costly and of very limited clinical value as a first line investigation for all patients with haematuria and should be omitted from guidelines.
Original languageEnglish
Pages (from-to)1255-1259
Number of pages5
JournalJournal of Urology
Volume189
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Hematuria
Cell Biology
Urine
Cystoscopy
Costs and Cost Analysis
Guidelines
Ureteroscopy
General Anesthetics
Teaching Hospitals
Neoplasms
Kidney
Biopsy
Sensitivity and Specificity

Keywords

  • urine
  • cytological techniques
  • hematuria
  • carcinoma
  • transitional cell

Cite this

Routine Urine Cytology Has no Role in Hematuria Investigations. / Mishriki, Said F. ; Aboumarzouk, Omar; Vint, Ross; Grimsley, Samuel J S; Lam, Thomas; Somani, Bhaskar.

In: Journal of Urology, Vol. 189, No. 4, 04.2013, p. 1255-1259.

Research output: Contribution to journalArticle

Mishriki, SF, Aboumarzouk, O, Vint, R, Grimsley, SJS, Lam, T & Somani, B 2013, 'Routine Urine Cytology Has no Role in Hematuria Investigations', Journal of Urology, vol. 189, no. 4, pp. 1255-1259. https://doi.org/10.1016/j.juro.2012.10.022
Mishriki, Said F. ; Aboumarzouk, Omar ; Vint, Ross ; Grimsley, Samuel J S ; Lam, Thomas ; Somani, Bhaskar. / Routine Urine Cytology Has no Role in Hematuria Investigations. In: Journal of Urology. 2013 ; Vol. 189, No. 4. pp. 1255-1259.
@article{47e65bd212ed4233b40817cac8a5436f,
title = "Routine Urine Cytology Has no Role in Hematuria Investigations",
abstract = "PURPOSE: Urine Cytology has been a longstanding first line investigation for haematuria and is recommended in current major guidelines. Objectives are to determine the contribution of urine cytology in haematuria investigations and its cost implications MATERIALS AND METHODS: Data prospectively collected for 2778 consecutive patients investigated for haematuria at a UK teaching hospital January 1999 to September 2007 with final analysis in October 2010. All patients underwent standard haematuria investigations; urine cytology, flexible cystoscopy and renal tract US with IVU or CTU performed for visible haematuria patients without diagnosis following first line tests. Patients with positive urine cytology as the only finding underwent further cystoscopy, retrograde studies or ureteroscopy with biopsy under general anaesthetic. Outcome in terms of eventual diagnosis were cross-referenced with initial urine cytology results (classified as malignant, suspicious, atypical, benign or unsatisfactory). Cost of urine cytology was calculated. RESULTS: 124 (4·5{\%}) patients had malignant cells and 260 (9·4{\%}) atypical/ suspicious. For urothelial cancer cytology demonstrated 45·5{\%} sensitivity and 89·5{\%} specificity. Two patients with urine cytology as the only positive finding had urothelial malignancy on further investigation. For the entire cohort, cost for cytology was £111,120. CONCLUSIONS: Routine urine cytology is costly and of very limited clinical value as a first line investigation for all patients with haematuria and should be omitted from guidelines.",
keywords = "urine, cytological techniques, hematuria, carcinoma, transitional cell",
author = "Mishriki, {Said F.} and Omar Aboumarzouk and Ross Vint and Grimsley, {Samuel J S} and Thomas Lam and Bhaskar Somani",
note = "Copyright {\circledC} 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.",
year = "2013",
month = "4",
doi = "10.1016/j.juro.2012.10.022",
language = "English",
volume = "189",
pages = "1255--1259",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Routine Urine Cytology Has no Role in Hematuria Investigations

AU - Mishriki, Said F.

AU - Aboumarzouk, Omar

AU - Vint, Ross

AU - Grimsley, Samuel J S

AU - Lam, Thomas

AU - Somani, Bhaskar

N1 - Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

PY - 2013/4

Y1 - 2013/4

N2 - PURPOSE: Urine Cytology has been a longstanding first line investigation for haematuria and is recommended in current major guidelines. Objectives are to determine the contribution of urine cytology in haematuria investigations and its cost implications MATERIALS AND METHODS: Data prospectively collected for 2778 consecutive patients investigated for haematuria at a UK teaching hospital January 1999 to September 2007 with final analysis in October 2010. All patients underwent standard haematuria investigations; urine cytology, flexible cystoscopy and renal tract US with IVU or CTU performed for visible haematuria patients without diagnosis following first line tests. Patients with positive urine cytology as the only finding underwent further cystoscopy, retrograde studies or ureteroscopy with biopsy under general anaesthetic. Outcome in terms of eventual diagnosis were cross-referenced with initial urine cytology results (classified as malignant, suspicious, atypical, benign or unsatisfactory). Cost of urine cytology was calculated. RESULTS: 124 (4·5%) patients had malignant cells and 260 (9·4%) atypical/ suspicious. For urothelial cancer cytology demonstrated 45·5% sensitivity and 89·5% specificity. Two patients with urine cytology as the only positive finding had urothelial malignancy on further investigation. For the entire cohort, cost for cytology was £111,120. CONCLUSIONS: Routine urine cytology is costly and of very limited clinical value as a first line investigation for all patients with haematuria and should be omitted from guidelines.

AB - PURPOSE: Urine Cytology has been a longstanding first line investigation for haematuria and is recommended in current major guidelines. Objectives are to determine the contribution of urine cytology in haematuria investigations and its cost implications MATERIALS AND METHODS: Data prospectively collected for 2778 consecutive patients investigated for haematuria at a UK teaching hospital January 1999 to September 2007 with final analysis in October 2010. All patients underwent standard haematuria investigations; urine cytology, flexible cystoscopy and renal tract US with IVU or CTU performed for visible haematuria patients without diagnosis following first line tests. Patients with positive urine cytology as the only finding underwent further cystoscopy, retrograde studies or ureteroscopy with biopsy under general anaesthetic. Outcome in terms of eventual diagnosis were cross-referenced with initial urine cytology results (classified as malignant, suspicious, atypical, benign or unsatisfactory). Cost of urine cytology was calculated. RESULTS: 124 (4·5%) patients had malignant cells and 260 (9·4%) atypical/ suspicious. For urothelial cancer cytology demonstrated 45·5% sensitivity and 89·5% specificity. Two patients with urine cytology as the only positive finding had urothelial malignancy on further investigation. For the entire cohort, cost for cytology was £111,120. CONCLUSIONS: Routine urine cytology is costly and of very limited clinical value as a first line investigation for all patients with haematuria and should be omitted from guidelines.

KW - urine

KW - cytological techniques

KW - hematuria

KW - carcinoma

KW - transitional cell

U2 - 10.1016/j.juro.2012.10.022

DO - 10.1016/j.juro.2012.10.022

M3 - Article

VL - 189

SP - 1255

EP - 1259

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -